ADRIAN GOTTSCHALK - 20 Aug 2021 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role: Chief Executive Officer, Director
Signature: /s /Allan Reine, M.D., Attorney-in-Fact for Adrian Gottschalk
Issuer symbol: FHTX
Transactions as of: 20 Aug 2021
Net transactions value: +$12,420
Form type: 4
Filing time: 23 Aug 2021, 17:01:35 UTC
Next filing: 28 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FHTX	Common Stock	Options Exercise	$12,420	+23,000	+5.4%	$0.5400^*	446,479	20 Aug 2021	Direct
holding	FHTX	Common Stock						25,225	20 Aug 2021	See Footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FHTX	Stock Options (Right to buy)	Options Exercise	$0	-23,000	-4.8%	$0.000000	458,925	20 Aug 2021	Common Stock	23,000	$0.5400	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee.
F2	The option vested as to 25% of the underlying shares of common stock on May 30, 2018, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.